Not applicableStudy completedNCT00960609What this trial is testingCommunicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound StudyWho this might be right forLiver Tumors University of Milan
Not applicableLooking for participantsNCT04655885What this trial is testingCardiac Output Optimization on Postoperative Complications in Major Hepatic SurgeryWho this might be right forPrimary or Metastatic Hepatic Adenocarcinoma Institut Paoli-Calmettes 186
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Study completedNCT00629759What this trial is testingRecombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic CarcinomaWho this might be right forNeoplasms, Liver Jennerex Biotherapeutics 14
Early research (Phase 1)Study completedNCT02181075What this trial is testingTargeted Chemotherapy Using Focused Ultrasound for Liver TumoursWho this might be right forLiver Tumour University of Oxford 10
Large-scale testing (Phase 3)Ended earlyNCT00151671What this trial is testingEffect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerWho this might be right forLiver CancerHepatocellular CarcinomaCirrhosis+1 more Rennes University Hospital 35
Early research (Phase 1)Study completedNCT01437007What this trial is testingTKM 080301 for Primary or Secondary Liver CancerWho this might be right forColorectal Cancer With Hepatic MetastasesPancreas Cancer With Hepatic MetastaseGastric Cancer With Hepatic Metastase+2 more National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Early research (Phase 1)Study completedNCT00978107What this trial is testingTrial of TG4023 Combined With Flucytosine in Liver TumorsWho this might be right forHepatocellular Carcinoma Transgene 16
Testing effectiveness (Phase 2)Study completedNCT00003907What this trial is testingChemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverWho this might be right forLiver CancerMetastatic Cancer Eastern Cooperative Oncology Group 50
Not applicableStudy completedNCT02202317What this trial is testingFollow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver TumorsWho this might be right forLiver CancerHepatic Tumors University of Miami 9
Testing effectiveness (Phase 2)Ended earlyNCT00019604What this trial is testingRadiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver CancerWho this might be right forLiver CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 44
Early research (Phase 1)Study completedNCT00960557What this trial is testingSafety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor BurdenWho this might be right forNeoplasm Metastasis Mateon Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00055692What this trial is testingBevacizumab in Treating Patients With Unresectable Nonmetastatic Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132